Designed to provide broad exposure to the Health Care ETFs category of the market, the Invesco Biotechnology & Genome ETF (PBE) is a smart beta exchange traded fund launched on 06/23/2005. What Are ...

Central Carolina Community College alumni working in the biotechnology industry took center stage at a recent biotechnology networking event held at the Dennis A. Wicker Civic & Conference Center in ...

Buffett’s casino comments raise an uncomfortable truth. Is biotechnology an investment, or is it more of a gambling casino? The honest answer is that it can be either.

Scientists at the Department of Energy's Oak Ridge National Laboratory have created a platform that pinpoints genetic ...

Launched on June 23, 2005, the Invesco Biotechnology & Genome ETF (PBE) is a passively managed exchange traded fund designed to provide a broad exposure to the Healthcare - Biotech segment of the ...

UC Santa Cruz deepens industry engagement to underscore its vital role in contributing basic research and tomorrow’s talent, convening its first international RNA biotech conference on August 18 ...

"Biotechnology" is a term commonly applied to the development of new medicines and therapies, the development of genetically modified plants, biofuels, biological treatment, or the production of ...

Microbial biotechnology is a dynamic field, The origins of microbiology can be traced back to the pioneering research by scientists such as Louis Pasteur and Robert Koch in the 19 th century. Within a ...

Biotechnology is a curious marriage of two seemingly disparate worlds. On one end, we have living organisms—wild, unpredictable celestial creations that can probably never be understood or appreciated ...

Updated Phase 1 dose-escalation data (n=58) show VIR-5500 monotherapy has a favorable safety profile and was well tolerated with no dose-limiting toxicities observed to date - Dose-dependent anti-tumo ...

Operator: Hello and welcome to Vir Biotechnology's Second Quarter 2026 Financial Results and Corporate Update Conference Call. As a reminder, this call is being recorded. [Operator Instructions] I ...

IASO Biotechnology ('IASO Bio) today announced the completion of its acquisition of MediSix Therapeutics ('MediSix'), a Singapore-based immune cell engineering and cell therapy company.